Different Ultrafiltration Rates and Intradialytic Hypotension.
NCT ID: NCT06695923
Last Updated: 2025-12-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2025-02-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Search About Contributing Factors That Leading to Intradialytic Hypertension in Hemodialysis Patients
NCT07069491
Prevention of Intradialytic Hypotension in Acute Kidney Injury Patients
NCT00971971
Quantification of Autonomic Nervous Activity During Hemodialysis
NCT02754986
Renal Resistive Index as a Predictor of Acute Kidney Injury and Evaluation of Fluid Administration in Sepsis
NCT06009445
The Validity of the Evaluation of Renal Artery Duplex in Critically Ill Acute Kidney Injury Patients
NCT07073508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Thus identifying the optimal cut off of ultrafiltration rate points for each patient
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
\-
Exclusion Criteria
Patients on recent haemodialysis \< 3 months.
Pregnant women.
Patients with malignancy, severe infections or sepsis.
Patients with major bleeding.
Patients who cannot go upper limb monitoring of blood pressure.
Patients with severe heart failure (NYHA) class 3 or more.
Patients with severe anemia, Hemoglobin less than 6 g/dl.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mahmoud Gad
Principal investigator and Resident in Internal medicine department, Sohag University Hospitals
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sohag University Hospitals,Faculty of medicine
Sohag, Sohag Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Emad A Mohamad
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Soh-Med--24-11-12MS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.